Financial Performance - The company's operating revenue for 2022 was CNY 1,982,523,522.63, representing a year-over-year increase of 15.85% compared to CNY 1,711,264,153.80 in 2021[35]. - The net profit attributable to shareholders for 2022 was CNY 67,991,994.56, which is a 9.25% increase from CNY 62,234,402.40 in 2021[35]. - The total assets as of the end of 2022 amounted to CNY 748,262,639.23, a decrease of 1.43% from CNY 759,095,955.22 at the end of 2021[37]. - The total liabilities decreased by 16.33% to CNY 185,356,756.95 in 2022 from CNY 221,538,067.50 in 2021[37]. - The cash flow from operating activities for 2022 was CNY 14,427,235.81, reflecting a significant decline of 85.93% compared to CNY 102,502,903.62 in 2021[39]. - The weighted average return on equity for 2022 was 12.44%, slightly up from 12.19% in 2021[35]. - The gross profit margin is influenced by customer structure, product structure, and fluctuations in precious metal prices, indicating a strong overall profitability despite a lower margin level[15]. - The gross profit margin for the company's main business was 4.92%, 4.99%, and 5.02% for the years 2020, 2021, and 2022 respectively, reflecting a relatively low level consistent with industry characteristics[14]. Customer and Supplier Concentration - The company reported sales to its top five customers amounting to RMB 1,604.35 million, representing 80.92% of total revenue, indicating a high customer concentration risk[13]. - The company has a high supplier concentration, which poses risks related to the stability of raw material quality and delivery times[12]. - The company’s major customers accounted for 80.92% of total sales, indicating a high concentration risk[80]. - The company’s major suppliers accounted for 64.03% of total purchases, highlighting a significant supplier concentration risk[82]. Research and Development - The company plans to continue investing in R&D for downstream applications in internal combustion engine exhaust purification, basic chemicals, and hydrogen energy to enhance industry position and product competitiveness[15]. - The company reported a research and development expenditure of 78,776,846.52 yuan, which accounted for 3.97% of operating income, up from 3.59% in the previous year[98]. - The company has a total of 22 R&D personnel, representing 29.85% of the total workforce, an increase from 28.95% in the previous year[100]. - The company is actively developing new products, including platinum-based catalysts, which have completed pilot and scale-up production[56]. - The company is focusing on the development of new generation platinum precursors that meet higher emission standards, ensuring product line upgrades[1]. - The company is developing a new generation of palladium-rhodium precursor for exhaust purification catalysts, aiming to meet higher emission standards[102]. - The company is collaborating with domestic chemical research institutes to promote palladium/alumina catalysts in coal and natural gas chemical sectors[54]. Strategic Initiatives - The company signed a strategic cooperation framework agreement with Shanghai Yihydrogen Technology Co., Ltd. to develop a new platinum-based catalyst for hydrogen energy batteries, aiming to create a new profit growth point[5]. - The company aims to deepen strategic cooperation with upstream industries to enhance its competitive edge in the precious metals recycling industry[31]. - The company has established a new subsidiary, Kaida Resources, with a registered capital of CNY 50 million, holding a 51% stake, to enhance its capabilities in precious metal refining and processing[30][31]. - The company is expanding its production capacity with a new facility expected to add 200 tons of precious metal catalyst production annually upon completion[55]. - The company is actively expanding into the hydrogen fuel cell catalyst materials sector, with a target of 100,000 hydrogen fuel cell vehicles in China by 2025, creating substantial market demand[62]. Risks and Challenges - The company faces risks related to the volatility of precious metal prices, which constitute over 99% of its operating costs, impacting both revenue and profitability[14]. - The company is exposed to risks associated with the potential shortage of precious metal resources due to reliance on imports and geopolitical factors[14]. - The company has faced risks related to technology innovation, including high difficulty, large investment, and long cycles for new product development, which could adversely affect market position and profitability[15]. - The company is exposed to risks from potential shortages of precious metal resources and significant fluctuations in gross profit margins due to market competition[16]. - The company has identified new risk factors, including risks related to import substitution and core technology leakage, and has conducted a systematic analysis of these risks[141]. Corporate Governance and Control - The actual controllers hold a combined 33.2048% of the shares, which poses a risk to the stability of the company's control if the agreement is not renewed[16]. - The company signed a "consensus action agreement" to ensure the stability of control, which is effective for 36 months post-IPO[140]. - The company has implemented measures to improve internal control and risk prevention capabilities, ensuring compliance with legal and regulatory requirements[128]. - The company has established a framework for managing related party transactions and external guarantees, ensuring compliance with relevant regulations[155]. - The controlling shareholders have pledged to minimize related party transactions and ensure they are conducted at fair market prices[157]. Market Position and Competitive Edge - The company aims to replace imported products with its self-developed products, competing with international chemical giants in terms of quality and performance[14]. - The company has achieved stable quality and good performance in its main product, automotive exhaust purification catalysts, gradually replacing foreign products[59]. - The company is committed to continuous innovation in precious metal catalytic materials, enhancing its R&D team and collaborating with academic institutions to strengthen its competitive edge[127]. - The company has established a significant market entry barrier through its advanced analysis and detection systems for precious metal catalysts[192]. - The company is focusing on the development of new palladium/alumina catalysts, with 2 tons of platinum/alumina catalysts provided for trial use, showing stable performance and potential as a new growth point[123]. Inventory and Asset Management - The company has established a relatively complete inventory management system, primarily adopting a "sales-based production and order-based procurement" model to mitigate the risk of precious metal price fluctuations[15]. - The inventory turnover rate improved to 8.52 in 2022 from 7.63 in 2021[39]. - The ending inventory value of Kaida Catalytic Company is ¥185,164,430.12, accounting for 24.75% of total assets[109]. - The company has improved its raw material separation and purification technology, enhancing its profit margins while expanding its resource base[135]. Shareholder and Equity Information - The company issued 11.5 million new shares, increasing its total share capital from 152.3 million to 163.8 million shares following its listing on the Beijing Stock Exchange[29]. - The total share capital remains unchanged at 152,300,000 shares, with 306 shareholders reported[184]. - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 15.01% of total shares[187]. - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 5.15% of total shares, reflecting a decrease of 10,000 shares[187]. - The company has clarified that there are no direct or indirect equity relationships with its underwriting and auditing institutions, ensuring transparency[178].

Financial Performance - Net profit attributable to shareholders for Q1 2023 was CNY 14.67 million, a decrease of 38.70% compared to CNY 23.92 million in Q1 2022[10] - Operating revenue for Q1 2023 was CNY 389.69 million, down 32.07% from CNY 573.64 million in the same period last year[10] - The total comprehensive income for the period was CNY 12,546,459.89, compared to CNY 23,759,453.70 in the previous period[46] - Total operating revenue for Q1 2023 was CNY 389.69 million, a decrease of 32.2% compared to CNY 573.64 million in Q1 2022[40] - Total operating costs for Q1 2023 were CNY 370.98 million, down from CNY 545.40 million in Q1 2022, reflecting a cost reduction of 32.0%[40] - Net profit for Q1 2023 was CNY 14.67 million, a decline of 38.7% from CNY 23.92 million in Q1 2022[42] - Earnings per share for Q1 2023 were CNY 0.09, compared to CNY 0.16 in Q1 2022, indicating a 43.8% decrease[42] Assets and Liabilities - Total assets as of March 31, 2023, amounted to CNY 757.63 million, reflecting a 1.25% increase from CNY 748.26 million at the end of 2022[10] - The company’s total liabilities to total assets ratio (consolidated) improved to 16.93% from 24.77% at the end of the previous year[10] - Total liabilities decreased to ¥128,242,420.53 from ¥185,356,756.95, a reduction of about 30.73%[34] - The company’s total assets reached CNY 815.33 million, up from CNY 752.28 million, marking an increase of 8.4%[38] - Total equity increased to CNY 612.93 million from CNY 548.57 million, representing an increase of 11.7%[38] Cash Flow - The company's cash flow from operating activities showed a net inflow of CNY 21.55 million, a significant improvement of 134.63% compared to a net outflow of CNY 62.23 million in the previous year[10][14] - Cash inflow from operating activities was CNY 428,097,491.73, down from CNY 506,187,591.70 year-over-year, representing a decrease of approximately 15.4%[47] - The net cash flow from operating activities was CNY 21,546,869.84, a significant improvement from a net outflow of CNY 62,228,327.99 in the same period last year[47] - The ending cash and cash equivalents balance was CNY 215,353,899.90, up from CNY 176,327,629.87 year-over-year[48] - The company reported a decrease in cash received from sales of goods and services to CNY 423,198,699.31 from CNY 496,176,465.78, reflecting a decline of approximately 14.7%[47] Shareholder Information - The total shareholding of the top ten shareholders is 66,786,162 shares, representing 41.15% of the total shares[21] - The largest shareholder, Yao Hong, holds 22,855,369 shares, accounting for 14.08% of the total shares[21] - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 4.84% of the total shares[21] - The total number of shares held by the top ten shareholders decreased by 478,338 shares during the reporting period[21] Borrowings and Financing - Short-term borrowings decreased by 86.21%, indicating a reduction in short-term financing needs[12] - The company’s long-term borrowings increased by 998.73% due to obtaining a three-year bank loan[12] - The company reported a significant reduction in short-term borrowings from ¥46,400,000.00 to ¥6,400,000.00, a decrease of approximately 86.16%[33] - The net cash flow from financing activities was CNY 50,298,888.10, compared to CNY 9,649,375.00 in the previous year, indicating a substantial increase[48] Operational Insights - The company reported a credit impairment loss of CNY 1.57 million in Q1 2023, compared to CNY 0.17 million in Q1 2022, indicating a significant increase in credit risk[41] - Research and development expenses for Q1 2023 were CNY 1.60 million, up from CNY 1.26 million in Q1 2022, showing a growth of 27.0%[41] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[34] - The company plans to focus on market expansion and new product development to drive future growth[40] Legal and Compliance - The company has no ongoing litigation or arbitration matters during the reporting period[24] - There are no external guarantees or loans provided by the company during the reporting period[24] - The company has fulfilled all disclosed commitments without any overdue situations[26] - The company has not engaged in any significant related party transactions during the reporting period[24] - There are no assets that have been seized, frozen, or pledged during the reporting period[24] - The company has not faced any investigations or penalties during the reporting period[24]

证券代码：830974 证券简称：凯大催化 公告编号：2023-034 （二）适用期限 2023 年 1 月 1 日至 2023 年 12 月 31 日 （三）薪酬标准 杭州凯大催化金属材料股份有限公司 关于 2023 年度公司董事、监事及高级管理人员薪酬方案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 杭州凯大催化金属材料股份有限公司（以下简称"公司"）根据《公司法》 《公司章程》及相关法律、法规和规范性文件的规定，结合经营发展等实际情况， 参考行业、地区薪酬水平，制定了 2023 年度董事、监事及高级管理人员薪酬方 案，现将具体情况公告如下： 一、2023 年度董事、监事及高级管理人员薪酬方案 （一）适用对象 公司董事、监事、高级管理人员 1、公司董事薪酬方案 （1）公司非独立董事在公司担任管理职务者或参与公司管理的，根据其在公 司所担任的管理职务或岗位领取薪酬；未在公司担任管理职务的非独立董事，不在 公司领取薪酬或津贴； （2）公司独立董事职务津贴为 6 万元/年（税后）。 2、公司监事 ...

证券代码：830974 证券简称：凯大催化 公告编号：2023-022 杭州凯大催化金属材料股份有限公司 第三届监事会第十四次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 4 月 24 日 2.会议召开地点：全资子公司浙江凯大催化新材料有限公司会议室（浙江省湖州 市长兴县城南工业园区经五路 8 号） 3.会议召开方式：现场和通讯 4.发出监事会会议通知的时间和方式：2023 年 4 月 13 日以书面方式发出 5.会议主持人：监事会主席邬学军先生 6.召开情况合法、合规、合章程性说明： 会议的召集、召开和表决程序符合有关法律、法规及《公司章程》的有关规 定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 监事唐忠、孙昶扬因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于 2022 年年度报告及摘要的议案》 1.议案内容： 根据 2022 年度公司情况编写了 2022 ...

证券代码：830974 证券简称：凯大催化 公告编号：2023-043 杭州凯大催化金属材料股份有限公司 独立董事提名人声明 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 提名人杭州凯大催化金属材料股份有限公司董事会，现提名朱建林、史莉佳、 彭兵为杭州凯大催化金属材料股份有限公司第四届董事会独立董事候选人，并已充 分了解被提名人职业专长、教育背景、工作经历、兼任职务等情况。被提名人已书 面同意出任杭州凯大催化金属材料股份有限公司第四届董事会独立董事候选人（参 见独立董事候选人声明）。提名人认为，被提名人具备独立董事任职资格，与山杭 州凯大催化金属材料股份有限公司之间不存在任何影响其独立性的关系，具体声明 如下： 一、被提名人已同时符合以下条件： （一）具备上市公司运作的基本知识，熟悉相关法律法规、部门规章、规范性 文件及北交所业务规则； （二）具有五年以上法律、经济、财务、管理或者其他履行独立董事职责所必 需的工作经验； （三）北交所规定的其他条件。 二、被提名人任职资格符合下列法律法规、部门规章、规 ...

证券代码：830974 证券简称：凯大催化 公告编号：2023-031 杭州凯大催化金属材料股份有限公司董事、监事换届公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、换届基本情况 （一）董事会换届的基本情况 根据《公司法》及公司章程的有关规定，公司第三届董事会第二十次会议于 2023 年 4 月 24 日审议并通过： 提名姚洪先生为公司董事，任职期限三年，本次换届尚需提交股东大会审议，自 2022 年年度股东大会决议通过之日起生效。上述提名人员持有公司股份 22,855,369 股， 占公司股本的 13.95%，不是失信联合惩戒对象。 提名谭志伟先生为公司董事，任职期限三年，本次换届尚需提交股东大会审议，自 2022 年年度股东大会决议通过之日起生效。上述提名人员持有公司股份 4,060,300 股， 占公司股本的 2.48%，不是失信联合惩戒对象。 提名林桂燕女士为公司董事，任职期限三年，本次换届尚需提交股东大会审议，自 2022 年年度股东大会决议通过之日起生效。上述提名人员持有公司股份 5 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 作为杭州凯大催化金属材料股份有限公司（以下简称"公司"）的独立董事， 2022 年度，我们严格按照《公司法》《证券法》《全国中小企业股份转让系统挂牌 公司治理指引第 2 号——独立董事》《公司章程》等有关规定，认真、忠实、勤勉 地履行独立董事职责，发表客观、公正的独立意见，维护公司整体利益，尤其关注 中小投资者的合法权益不受损害。现将 2022 年履行独立董事职责情况汇报如下： 一、出席会议情况 2022 年度任职期间，我们积极参加公司召开的董事会和股东大会，认真行使独 立董事勤勉尽责的义务，根据相关法律和制度的规定，认真审议所有议案，并审慎 行使表决权。我们认为公司董事会、股东大会的召集、召开符合法定程序，重大经 营决策事项和其他重大事项均履行了相关审批程序，合法有效。因此，我们对 2022 年度任职期间提交董事会审议的各项议案均没有提出异议。出席有关会议情况如 | 下： | | | | | | | --- | --- | --- | --- | --- ...

关于杭州凯大催化金属材料股份有限公司 公司内部制度建设情况如下： 治理专项自查及规范活动的 专项核查报告 国金证券股份有限公司（以下简称"国金证券"、"保荐机构"）作为杭 州凯大催化金属材料股份有限公司（以下简称"凯大催化"、"公司"）的保 荐机构，根据《关于做好上市公司 2022 年年度报告披露相关工作的通知》（北 证办发〔2022〕62 号）（以下简称《通知》）及公司治理专项自查及规范活动 的要求，参考公司自查情况并结合日常督导情况，通过日常了解、查阅制度文 件、查阅三会资料、公开网站核查、获取相关声明等方式对 2022 年度凯大催化 的专项自查和自我规范情况进行了核查，具体情况如下： 国金证券股份有限公司 一、内部制度建设情况 公司董事会共 9人，其中独立董事 3人，会计专业独立董事 1人。公司监事 会共 3 人，其中职工代表监事 1 人。公司高级管理人员共 4 人，其中 2 人担任董 事。 2022 年度公司董事会、监事会设置是否存在以下特殊情况： | 事项 | 是或否 | | --- | --- | | 公司董事会中兼任高级管理人员的董事和职工代表担任的董 事，人数超过公司董事总数的二分之一 | 否 ...

证券代码：830974 证券简称：凯大催化 公告编号：2023-029 使用自有闲置资金购买理财产品的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、购买理财产品概述 （一）购买理财产品的目的 为了提高杭州凯大催化金属材料股份有限公司（以下简称"公司"）（含全资 子公司）自有闲置资金使用效率，合理利用资金获取较好的投资回报，在不影响公 司主营业务正常发展的前提下，公司拟使用自有闲置资金购买理财产品，为公司与 股东创造更大的收益。理财产品主要是安全性高、流动性好、可以保障投资本金安 全的理财产品。 （二）购买理财产品的额度和资金来源 在不影响公司主营业务正常发展的前提下，公司拟使用额度不超过 20,000 万元 的自有闲置资金购买理财产品。在上述额度及期限范围内，资金可以循环滚动使 用，即在投资期限内任意时点所持有的理财产品总额度不超过 20,000 万元人民币。 （三）购买理财产品的期限 期限自 2022 年年度股东大会审议通过之日起 12 个月内有效，如单笔产品的存 续期超过股东大会决议有效 ...

2022 年年度权益分派预案公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别 及连带法律责任。 杭州凯大催化金属材料股份有限公司（以下简称"公司"）于 2023 年 4 月 24 日召开第三届董事会第二十次会议、第三届监事会第十四次会议，审议通过 《关于 2022 年度权益分派预案的议案》，该议案尚需提交公司 2022 年年度股东 大会审议。现将该预案的有关情况公告如下： 一、权益分派预案情况 根据公司 2023 年 4 月 26 日披露的 2022 年年度报告（财务报告已经审计），截 至 2022 年 12 月 31 日，上市公司合并报表归属于母公司的未分配利润为 123,685,482.51 元，母公司未分配利润为 109,345,607.14 元。 结合公司 2022 年度经营情况及 2023 年度公司发展规划，经董事会讨论，2022 年度公司拟不派发现金股利，不送红股，不以资本公积金转增股本。本次权益分派 预案尚需提交股东大会审议。 二、审议及表决情况 （一）董事会审议和表决情况 证券代码：830974 证券 ...